• VENUS: Ustekinumab Superior to Vedolizumab for Refractory Crohn's

    29 days ago - By Medscape

    A study directly compares two biologic agents among patients with Crohn's disease who failed previous anti-TNF therapy.
    Medscape Medical News
    Read more ...